Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosdevirine in ART-experienced HIV-1
NCT01199731Phase 2Terminated
- Sponsor
- ViiV Healthcare
- Start
- Oct 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of Fosdevirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Oct 2010; status: terminated.
02
Drugs
Fosdevirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01199731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01199731.